Marek David C 4
4 · Myovant Sciences Ltd. · Filed Jul 20, 2022
Insider Transaction Report
Form 4
Marek David C
DirectorPrincipal Executive Officer
Transactions
- Sale
Common Shares
2022-07-18$12.87/sh−11,164$143,681→ 436,792 total
Footnotes (1)
- [F1]Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.